PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Recent Activity
2025Q4
1 sell
-7.79M shares(-29.4%)
-7.79M shares(-29.4%)
Loading more activity...
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies